Necrotizing Soft Tissue Infection

Early diagnosis of necrotizing soft tissue infection (NSTI) can be challenging due to its non-specific initial presentation. While swelling and erythema are common, they are not highly specific. Clinicians should prioritize a combination of clinical findings and laboratory markers for early and reliable diagnosis. These include severe pain disproportionate to physical exam findings, rapid progression of symptoms, crepitus on palpation, systemic toxicity (e.g., hypotension, tachycardia, fever), and laboratory abnormalities such as leukocytosis, elevated C-reactive protein (CRP), and metabolic acidosis. Imaging studies, particularly CT scans with contrast, can be helpful in identifying gas in the tissues, a hallmark sign of NSTI, but should not delay surgical intervention if clinical suspicion is high. Consider implementing a standardized diagnostic pathway for NSTI in your institution to improve early recognition. Explore how incorporating the LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score can aid in risk stratification and early diagnosis of NSTI.

Differentiating necrotizing soft tissue infection (NSTI) from cellulitis and other mimickers like abscesses or deep vein thrombosis (DVT) is crucial in the emergency setting due to the time-sensitive nature of NSTI management. While both NSTI and cellulitis present with erythema, swelling, and pain, NSTI often exhibits pain out of proportion to exam findings, rapid progression of symptoms, skin discoloration (e.g., dusky, violaceous, or bronze), bullae formation, crepitus, and signs of systemic toxicity. Unlike cellulitis, NSTI frequently involves deeper tissues, leading to decreased sensation in the affected area later in the disease course. Laboratory findings such as marked leukocytosis, elevated CRP, and metabolic acidosis further support NSTI diagnosis. Imaging, particularly CT with contrast, can reveal gas in soft tissues and help differentiate NSTI from cellulitis and other mimics. Given the high mortality rate associated with delayed treatment, a high index of suspicion is warranted. Learn more about the use of bedside ultrasound for rapid assessment of soft tissue involvement in suspected NSTI cases.

Surgical debridement is the cornerstone of treatment for confirmed necrotizing soft tissue infection (NSTI). Best practices involve aggressive and extensive debridement of all necrotic tissue, extending beyond the visibly affected margins to ensure complete removal of infected tissue. Intraoperative frozen section analysis can help determine the extent of tissue involvement and guide the debridement process. Post-operatively, the wound should be left open with frequent dressing changes using appropriate antiseptics or topical antimicrobial agents. Negative pressure wound therapy (NPWT) can be beneficial in promoting granulation tissue formation and managing wound exudate. Serial debridements may be necessary to address any residual necrotic tissue. Reconstructive surgery, such as skin grafting or flap closure, may be considered once the infection is controlled and healthy granulation tissue is present. Explore how implementing a multidisciplinary approach involving infectious disease specialists, plastic surgeons, and intensivists can optimize outcomes in NSTI patients. Consider implementing standardized post-operative wound care protocols to improve healing and minimize complications.